LMAT
Lemaitre Vascular Inc

502
Loading...
Loading...
News
all
press releases
Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think "Yes"
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·23d ago
News Placeholder
More News
News Placeholder
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve
enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure.
Zacks·25d ago
News Placeholder
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.
Zacks·27d ago
News Placeholder
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·1mo ago
News Placeholder
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of +5.26% and +2.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
PAHC vs. LMAT: Which Stock Is the Better Value Option?
Zacks·2mo ago
News Placeholder
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Latest Ratings for LMAT DateFirmActionFromTo Sep 2021JefferiesInitiates Coverage OnBuy Aug 2021Roth CapitalMaintainsNeutral May 2021Roth CapitalMaintainsNeutral View More Analyst Ratings for...
Benzinga·11mo ago
News Placeholder
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Latest Ratings for LMAT DateFirmActionFromTo Sep 2021JefferiesInitiates Coverage OnBuy Aug 2021Roth CapitalMaintainsNeutral May 2021Roth CapitalMaintainsNeutral View More Analyst Ratings for...
Benzinga·11mo ago
News Placeholder
Here's Why Investors Should Hold Teladoc (TDOC) Stock Now
Teladoc Health, Inc. TDOC is well-poised to grow on the back of rising access fees and the continuous adoption of telehealth services. Its expanding product offerings are likely to bring in more...
Zacks Investment Research·1y ago
News Placeholder
LeMaitre Vascular (LMAT, $67.01) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024
This indicator may be signaling LMAT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·1y ago

Latest LMAT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.